The landscape of diabetes management is rapidly shifting, with the emergence of dual GIP and GLP-1 receptor agonists. Both Tirzepatide and Retatrutide represent key advancements; The Tirzepatide already https://sashaqotk866544.tusblogos.com/43645959/tirzepatide-retatrutide-a-emerging-metabolic-health-combination